Psychiatric treatment of persons with HIV/AIDS: An HIV-psychiatry consensus survey of current practices

Oliver Freudenreich; Harold W. Goforth; Kelly L. Cozza; Matthew J. Mimiaga; Steven A. Safren; Grace Bachmann; Mary Ann Cohen

doi:10.1176/appi.psy.51.6.480

Psychiatric treatment of persons with HIV/AIDS: An HIV-psychiatry consensus survey of current practices

Oliver Freudenreich, Harold W. Goforth, Kelly L. Cozza, Matthew J. Mimiaga, Steven A. Safren, Grace Bachmann, Mary Ann Cohen

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Abstract

Background: Only sparse evidence from controlled clinical trials is available to guide the psychiatric treatment of persons with HIV/AIDS. Objective: The authors assessed and determined current treatment trends in AIDS psychiatry. Method: Members of the Organization of AIDS Psychiatry (OAP) participated in a web-based survey. Results: Of 159 members, 62 (39%) responded to the survey. Consensus emerged regarding first-line treatment for depression (escitalopram/ citalopram), for psychosis and secondary mania (quetiapine), and for anxiety (clonazepam). Conclusion: Consensus statements can serve as a preliminary step toward providing some standardization of care for persons with HIV/AIDS.

Original language	English (US)
Pages (from-to)	480-488
Number of pages	9
Journal	Psychosomatics
Volume	51
Issue number	6
DOIs	https://doi.org/10.1176/appi.psy.51.6.480
State	Published - 2010
Externally published	Yes

ASJC Scopus subject areas

Arts and Humanities (miscellaneous)
Applied Psychology
Psychiatry and Mental health

Access to Document

10.1176/appi.psy.51.6.480

Fingerprint Dive into the research topics of 'Psychiatric treatment of persons with HIV/AIDS: An HIV-psychiatry consensus survey of current practices'. Together they form a unique fingerprint.

Cite this

@article{ac29bf2e22324723b83e8c090b2d8a01,

title = "Psychiatric treatment of persons with HIV/AIDS: An HIV-psychiatry consensus survey of current practices",

abstract = "Background: Only sparse evidence from controlled clinical trials is available to guide the psychiatric treatment of persons with HIV/AIDS. Objective: The authors assessed and determined current treatment trends in AIDS psychiatry. Method: Members of the Organization of AIDS Psychiatry (OAP) participated in a web-based survey. Results: Of 159 members, 62 (39%) responded to the survey. Consensus emerged regarding first-line treatment for depression (escitalopram/ citalopram), for psychosis and secondary mania (quetiapine), and for anxiety (clonazepam). Conclusion: Consensus statements can serve as a preliminary step toward providing some standardization of care for persons with HIV/AIDS.",

author = "Oliver Freudenreich and Goforth, {Harold W.} and Cozza, {Kelly L.} and Mimiaga, {Matthew J.} and Safren, {Steven A.} and Grace Bachmann and Cohen, {Mary Ann}",

year = "2010",

doi = "10.1176/appi.psy.51.6.480",

language = "English (US)",

volume = "51",

pages = "480--488",

journal = "Psychosomatics",

issn = "0033-3182",

publisher = "American Psychiatric Publishing Inc.",

number = "6",

}

TY - JOUR

T1 - Psychiatric treatment of persons with HIV/AIDS

T2 - An HIV-psychiatry consensus survey of current practices

AU - Freudenreich, Oliver

AU - Goforth, Harold W.

AU - Cozza, Kelly L.

AU - Mimiaga, Matthew J.

AU - Safren, Steven A.

AU - Bachmann, Grace

AU - Cohen, Mary Ann

PY - 2010

Y1 - 2010

N2 - Background: Only sparse evidence from controlled clinical trials is available to guide the psychiatric treatment of persons with HIV/AIDS. Objective: The authors assessed and determined current treatment trends in AIDS psychiatry. Method: Members of the Organization of AIDS Psychiatry (OAP) participated in a web-based survey. Results: Of 159 members, 62 (39%) responded to the survey. Consensus emerged regarding first-line treatment for depression (escitalopram/ citalopram), for psychosis and secondary mania (quetiapine), and for anxiety (clonazepam). Conclusion: Consensus statements can serve as a preliminary step toward providing some standardization of care for persons with HIV/AIDS.

AB - Background: Only sparse evidence from controlled clinical trials is available to guide the psychiatric treatment of persons with HIV/AIDS. Objective: The authors assessed and determined current treatment trends in AIDS psychiatry. Method: Members of the Organization of AIDS Psychiatry (OAP) participated in a web-based survey. Results: Of 159 members, 62 (39%) responded to the survey. Consensus emerged regarding first-line treatment for depression (escitalopram/ citalopram), for psychosis and secondary mania (quetiapine), and for anxiety (clonazepam). Conclusion: Consensus statements can serve as a preliminary step toward providing some standardization of care for persons with HIV/AIDS.

UR - http://www.scopus.com/inward/record.url?scp=78649655790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649655790&partnerID=8YFLogxK

U2 - 10.1176/appi.psy.51.6.480

DO - 10.1176/appi.psy.51.6.480

M3 - Article

C2 - 21051679

AN - SCOPUS:78649655790

VL - 51

SP - 480

EP - 488

JO - Psychosomatics

JF - Psychosomatics

SN - 0033-3182

IS - 6

ER -

Psychiatric treatment of persons with HIV/AIDS: An HIV-psychiatry consensus survey of current practices

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this